Quarterly Report (10-q)

Q1--12-31false00017890290001789029aeva:TwelvePointFiveVestingPercentageMember2023-01-012023-03-3100017890292023-01-012023-03-310001789029us-gaap:OtherCurrentAssetsMember2023-03-310001789029us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001789029us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001789029aeva:TwoThousandSixteenStockIncentivePlanMember2023-03-310001789029us-gaap:ConstructionInProgressMember2023-03-310001789029aeva:TestingEquipmentMember2022-12-310001789029us-gaap:ConstructionInProgressMember2022-12-310001789029us-gaap:TransferredAtPointInTimeMember2023-01-012023-03-310001789029srt:MinimumMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2023-01-012023-03-310001789029srt:MaximumMemberaeva:EmployeeStockPurchasePlanMember2023-01-012023-03-310001789029us-gaap:CostOfSalesMember2023-01-012023-03-310001789029us-gaap:CommonStockMember2022-12-310001789029aeva:EmployeeStockPurchasePlanMember2023-03-310001789029us-gaap:MeasurementInputExpectedTermMember2023-03-3100017890292023-05-010001789029srt:AsiaMember2023-01-012023-03-310001789029aeva:EmployeeStockPurchasePlanMember2023-01-012023-03-310001789029aeva:ManufacturingEquipmentMember2023-03-310001789029us-gaap:CommonStockMember2021-12-310001789029aeva:PerformanceBasedRestrictedStockUnitsMember2023-01-012023-03-310001789029us-gaap:CommonStockMember2023-01-012023-03-310001789029aeva:OneYearMember2023-01-012023-03-310001789029srt:AsiaMember2022-12-310001789029aeva:ManufacturingEquipmentMember2022-12-310001789029us-gaap:RetainedEarningsMember2023-03-3100017890292022-01-012022-12-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMember2022-12-310001789029us-gaap:RetainedEarningsMember2023-01-012023-03-310001789029us-gaap:AdditionalPaidInCapitalMember2022-03-310001789029us-gaap:OtherCurrentLiabilitiesMember2023-03-310001789029srt:AsiaMember2022-01-012022-03-310001789029us-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001789029aeva:PrivateWarrantsMember2023-03-310001789029srt:EuropeMember2022-01-012022-03-310001789029us-gaap:ConvertiblePreferredStockMember2023-03-310001789029us-gaap:MeasurementInputExercisePriceMember2023-03-3100017890292022-12-3100017890292022-03-310001789029aeva:RemainingThirtySixMonthsMember2023-01-012023-03-310001789029us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-03-310001789029us-gaap:CommonStockMember2022-01-012022-03-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMember2022-01-012022-12-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMember2022-12-310001789029us-gaap:EMEAMember2022-12-310001789029us-gaap:CreditConcentrationRiskMemberaeva:CustomerOneMemberus-gaap:AccountsReceivableMember2023-01-012023-03-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMember2023-01-012023-03-310001789029us-gaap:RetainedEarningsMember2022-12-310001789029us-gaap:MeasurementInputDiscountRateMember2023-03-310001789029us-gaap:ConvertiblePreferredStockMember2022-12-310001789029us-gaap:AdditionalPaidInCapitalMember2023-03-310001789029srt:EuropeMember2023-01-012023-03-310001789029us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2022-12-310001789029us-gaap:AdditionalPaidInCapitalMember2021-12-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMember2023-03-310001789029us-gaap:LeaseholdImprovementsMember2022-12-310001789029aeva:EmployeeStockPurchasePlanMember2022-11-300001789029us-gaap:MeasurementInputRiskFreeInterestRateMember2023-03-310001789029us-gaap:MeasurementInputExercisePriceMember2022-12-310001789029us-gaap:WarrantMember2023-01-012023-03-310001789029us-gaap:FairValueInputsLevel3Memberaeva:WarrantLiabilitiesMember2023-03-310001789029us-gaap:CostOfSalesMember2022-01-012022-03-310001789029us-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001789029us-gaap:CommonStockMember2023-03-310001789029us-gaap:MoneyMarketFundsMember2023-03-310001789029us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001789029us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2023-03-310001789029srt:NorthAmericaMember2022-12-310001789029srt:MaximumMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2022-01-012022-03-3100017890292022-01-012022-03-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2023-01-012023-03-310001789029us-gaap:FairValueInputsLevel2Member2023-03-310001789029us-gaap:StockOptionMember2022-01-012022-03-310001789029us-gaap:FairValueInputsLevel2Member2022-01-012022-12-310001789029aeva:TwentyFiveVestingPercentageMember2023-01-012023-03-310001789029us-gaap:AdditionalPaidInCapitalMember2022-12-310001789029us-gaap:TransferredOverTimeMember2022-01-012022-03-310001789029us-gaap:MeasurementInputDiscountRateMember2022-12-310001789029us-gaap:EquipmentMember2022-12-310001789029us-gaap:EMEAMember2023-03-310001789029us-gaap:CreditConcentrationRiskMemberaeva:CustomerOneMemberus-gaap:AccountsReceivableMember2022-01-012022-12-310001789029us-gaap:CommonStockMember2022-03-310001789029us-gaap:MeasurementInputRiskFreeInterestRateMember2022-12-310001789029us-gaap:StockOptionMember2023-03-310001789029us-gaap:TransferredOverTimeMember2023-01-012023-03-310001789029us-gaap:EquipmentMember2023-03-310001789029us-gaap:SellingAndMarketingExpenseMember2022-01-012022-03-310001789029us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2023-03-310001789029us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-03-310001789029us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001789029aeva:TwoVendorsMemberus-gaap:CreditConcentrationRiskMemberus-gaap:AccountsPayableMember2022-01-012022-12-310001789029srt:NorthAmericaMember2022-01-012022-03-310001789029us-gaap:OtherCurrentLiabilitiesMember2022-12-310001789029us-gaap:MeasurementInputPriceVolatilityMember2022-12-310001789029us-gaap:FurnitureAndFixturesMember2022-12-310001789029us-gaap:ComputerEquipmentMember2023-03-310001789029aeva:PublicWarrantsMember2023-03-310001789029aeva:TestingEquipmentMember2023-03-310001789029us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001789029us-gaap:MeasurementInputExpectedTermMember2022-12-310001789029srt:NorthAmericaMember2023-03-310001789029us-gaap:RestrictedStockUnitsRSUMember2022-12-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-01-012022-12-310001789029us-gaap:StockOptionMember2023-01-012023-03-310001789029aeva:TwoVendorsMemberus-gaap:CreditConcentrationRiskMemberus-gaap:AccountsPayableMember2023-01-012023-03-310001789029us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001789029us-gaap:RestrictedStockUnitsRSUMember2023-03-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2023-01-012023-03-3100017890292023-03-310001789029us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001789029us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-03-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMember2022-01-012022-12-3100017890292021-12-310001789029aeva:PerformanceBasedRestrictedStockUnitsMember2023-03-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMember2023-01-012023-03-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMember2023-03-310001789029us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001789029aeva:FirstTwelveMonthsMember2023-01-012023-03-310001789029us-gaap:FairValueInputsLevel3Memberaeva:WarrantLiabilitiesMember2022-12-310001789029us-gaap:WarrantMember2023-01-012023-03-310001789029us-gaap:FairValueInputsLevel2Member2023-01-012023-03-310001789029us-gaap:SellingAndMarketingExpenseMember2023-01-012023-03-310001789029us-gaap:OtherCurrentAssetsMember2022-12-310001789029srt:AsiaMember2023-03-310001789029srt:NorthAmericaMember2023-01-012023-03-310001789029us-gaap:MeasurementInputPriceVolatilityMember2023-03-310001789029us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2022-12-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2023-03-310001789029us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-03-310001789029us-gaap:RetainedEarningsMember2021-12-310001789029us-gaap:RetainedEarningsMember2022-03-310001789029us-gaap:FurnitureAndFixturesMember2023-03-310001789029us-gaap:TransferredAtPointInTimeMember2022-01-012022-03-310001789029us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2022-01-012022-12-310001789029us-gaap:WarrantMember2022-01-012022-03-310001789029us-gaap:RetainedEarningsMember2022-01-012022-03-310001789029us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001789029us-gaap:ComputerEquipmentMember2022-12-310001789029us-gaap:LeaseholdImprovementsMember2023-03-310001789029aeva:SixMonthsMember2023-01-012023-03-310001789029us-gaap:FairValueInputsLevel2Member2022-12-310001789029us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-31iso4217:USDxbrli:sharesaeva:Customerxbrli:purexbrli:sharesaeva:Segmentiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission File Number: 001-39204

 

AEVA TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware	84-3080757
( State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
555 Ellis Street Mountain View, CA	94043
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: [phone]

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, $0.0001 par value per share		AEVA		New York Stock Exchange
Warrants to purchase one share of common stock		AEVA.WS		New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer		☐		Accelerated filer		☐
Non-accelerated filer		☒		Smaller reporting company		☒
Emerging growth company		☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 1, 2023, the registrant had 220,360,889 shares of common stock, $0.0001 par value per share, outstanding.

 

 

---

 

Table of Contents

 

		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	4
	Condensed Consolidated Balance Sheets	4
	Condensed Consolidated Statements of Operations	5
	Condensed Consolidated Statements of Stockholders' Equity	6
	Condensed Consolidated Statements of Cash Flows	8
	Notes to the Condensed Financial Statements (Unaudited)	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	22
Item 4.	Controls and Procedures	22
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	23
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	23
Item 3.	Defaults Upon Senior Securities	23
Item 4.	Mine Safety Disclosures	23
Item 5.	Other Information	23
Item 6.	Exhibits	24
Signatures		25

 

 

 

 

---

Table of Contents

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) regarding future events and our future results that are subject to the safe harbors created under the Securities Act and the Exchange Act. All statements contained in this report other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “goal,” “plan,” “intend,” “expect,” “seek”, and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 under the heading “Risk Factors.” Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

You should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. We are under no duty to update any of these forward-looking statements after the date of this report or to conform these statements to actual results or revised expectations.

As used in this report, the terms “Aeva,” “we,” “us,” “our,” and “the Company” mean Aeva Technologies, Inc. and its subsidiaries unless the context indicates otherwise.

 

3

---

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

AEVA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS, EXCEPT PAR VALUE)

(UNAUDITED)

 

		March 31, 2023				December 31, 2022
Assets
Cash and cash equivalents		$	31,864			$	67,420
Marketable securities			256,542				256,392
Accounts receivable			2,445				2,887
Inventories			3,006				2,951
Other current assets			4,683				5,473
Total current assets			298,540				335,123
Operating lease right-of-use assets			6,658				7,402
Property, plant and equipment, net			10,689				9,720
Intangible assets, net			3,300				3,525
Other noncurrent assets			862				862
Total assets		$	320,049			$	356,632
Liabilities and stockholders' equity
Accounts payable		$	3,857			$	5,182
Accrued liabilities			3,856				9,063
Accrued employee costs			3,414				4,721
Lease liability, current portion			2,535				2,667
Other current liabilities			194				194
Total current liabilities			13,856				21,827
Lease liability, noncurrent portion			4,167				4,789
Warrant liability			62				90
Total liabilities			18,085				26,706
Commitments and contingencies (Note 12)
Convertible preferred stock $0.0001 par value; 10,000 shares authorized; no shares issued and outstanding			—				—
Common stock $0.0001 par value; 422,000 shares authorized; 220,050 and 218,748 shares issued    and outstanding at March 31, 2023 and December 31, 2022, respectively			22				22
Additional paid-in capital			649,756				643,756
Accumulated other comprehensive loss			(2,373	)			(3,585	)
Accumulated deficit			(345,441	)			(310,267	)
Total stockholders' equity			301,964				329,926
Total liabilities and stockholders' equity		$	320,049			$	356,632

 

4

---

Table of Contents

AEVA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)

(UNAUDITED)

 

		Three Months Ended March 31,
		2023				2022
Revenue		$	1,148			$	1,137
Cost of revenue			2,529				1,375
Gross loss			(1,381	)			(238	)
Operating expenses:
Research and development expenses			25,454				25,315
General and administrative expenses			7,833				6,872
Selling and marketing expenses			2,598				1,648
Total operating expenses			35,885				33,835
Operating loss			(37,266	)			(34,073	)
Interest income			2,064				283
Other income, net			28				633
Loss before income taxes			(35,174	)			(33,157	)
Income tax provision			—				—
Net loss		$	(35,174	)		$	(33,157	)
Unrealized gain (loss) on available-for-sale securities			1,212				(2,455	)
Total comprehensive loss		$	(33,962	)		$	(35,612	)
Net loss per share, basis and diluted		$	(0.16	)		$	(0.15	)
Weighted-average shares used in computing net loss per share, basic and diluted			219,627,827				216,017,186

 

5

---

Table of Contents

AEVA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(IN THOUSANDS, EXCEPT SHARE DATA)

(UNAUDITED)

 

														Accumulated
		Common stock								Additional paid-in				Other Comprehensive				Accumulated				Total stockholders'
​		Shares				Amount				capital				loss				deficit				equity
Balance at December 31, 2022			218,748,423			$	22			$	643,756			$	(3,585	)		$	(310,267	)		$	329,926
Share-based compensation			—				—				5,963				—				—				5,963
Issuance of common stock upon exercise of stock    options			236,642				—				57				—				—				57
Issuance of common stock upon release of restricted    stock units			1,077,527				—				—				—				—				—
Shares withheld for the withholding tax on vesting of restricted    stock units			(12,497	)			—				(20	)			—				—				(20	)
Unrealized gain on available-for-sale securities			—				—				—				1,212				—				1,212
Net loss			—				—				—				—				(35,174	)			(35,174	)
Balance as of March 31, 2023			220,050,095			$	22			$	649,756			$	(2,373	)	`	$	(345,441	)		$	301,964

 

6

---

Table of Contents

AEVA TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(IN THOUSANDS, EXCEPT SHARE DATA)

(UNAUDITED)

														Accumulated
		Common stock								Additional paid-in				Other Comprehensive				Accumulated				Total stockholders'
​		Shares				Amount				capital				loss				deficit				equity
Balance at December 31, 2021			214,997,014			$	21			$	619,841			$	(524	)		$	(162,962	)		$	456,376
Share-based compensation			—				—				5,784				—				—				5,784
Issuance of common stock upon exercise of stock    options			1,029,266				1				185				—				—				186
Issuance of common stock upon release of restricted    stock units			671,621				—				—				—				—				—
Shares withheld for the withholding tax on vesting of restricted    stock units			(53,553	)			—				(244	)			—				—				(244	)
Issuance of common stock upon exercise of warrants			120				—				1				—				—				1
Unrealized loss on available-for-sale securities			—				—				—				(2,455	)			—				(2,455	)
Net loss			—				—				—				—				(33,157	)			(33,157	)
Balance as of March 31, 2022			216,644,468			$	22			$	625,567			$	(2,979	)	`	$	(196,119	)		$	426,491

 

7

---

Table of Contents

AEVA TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

(UNAUDITED)

 

		Three Months Ended March 31,
		2023				2022
Cash flows from operating activities:
Net loss		$	(35,174	)		$	(33,157	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization			955				630
Impairment of inventories			45				767
Change in fair value of warrant liability			(28	)			(634	)
Stock-based compensation			5,963				5,784
Amortization of right-of-use assets			744				707
Amortization of premium and accretion of discount on available-for-sale securities, net			(632	)			435
Changes in operating assets and liabilities:
Accounts receivable			442				2,130
Inventories			(100	)			(312	)
Other current assets			790				403
Other noncurrent assets			—				(1	)
Accounts payable			(1,749	)			1,890
Accrued liabilities			(5,207	)			(2,653	)
Accrued employee costs			(1,307	)			(1,332	)
Lease liability			(754	)			(696	)
Other current liabilities			—				(499	)
Net cash used in operating activities			(36,012	)			(26,538	)
Cash flows from investing activities:
Purchase of property, plant and equipment			(1,275	)			(1,283	)
Purchase of available-for-sale securities			(54,520	)			(82,284	)
Proceeds from maturities of available-for-sale securities			56,214				105,607
Net cash provided by investing activities			419				22,040
Cash flows from financing activities:
Payments of taxes withheld on net settled vesting of restricted stock units			(20	)			—
Proceeds from exercise of warrants			—				1
Proceeds from exercise of stock options			57				186
Net cash provided by financing activities			37				187
Net decrease in cash and cash equivalents			(35,556	)			(4,311	)
Beginning cash and cash equivalents			67,420				66,810
Ending cash and cash equivalents		$	31,864			$	62,499
Supplemental disclosures of cash flow information:
Cash paid for interest		$	—			$	—
Cash paid for income taxes		$	—			$	—
Supplemental disclosures of non-cash investing and financing activities:
Unpaid property, plant and equipment purchases		$	503			$	1,265
Taxes withheld on net settled vesting of restricted stock units		$	—			$	244

 

8

---

Table of Contents

AEVA TECHNOLOGIES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Note 1. Description of Business and Summary of Significant Accounting Policies

Description of Business

Aeva Technologies, Inc. (the “Company”), through its Frequency Modulated Continuous Wave (“FMCW”) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation and security application.

 

On March 12, 2021 (the “Closing Date”), Aeva, Inc. consummated a business combination (the “Business Combination”) with InterPrivate Acquisition Corp. (the Company’s predecessor, which was originally incorporated in Delaware as a special purpose acquisition company (“IPV”)) pursuant to the Business Combination Agreement dated as of November 2, 2020 (the “BCA”), by and among IPV, WLLY Merger Sub Corp., a wholly owned subsidiary of IPV, and Aeva, Inc. Immediately upon the consummation of the Business Combination, WLLY Merger Sub Corp. merged with and into Aeva, Inc., with Aeva, Inc. surviving the merger as a wholly owned subsidiary of IPV. IPV changed its name to Aeva Technologies, Inc. and the pre-combination Aeva retained its name of Aeva, Inc. Aeva, Inc. was incorporated in the State of Delaware on December 5, 2016 and is headquartered in Mountain View, California. Unless the context otherwise requires, “we,” “us,” “our,” “Aeva,” and the “Company” refers to Aeva Technologies Inc., the combined company and its subsidiaries following the Business Combination. Refer to Reverse Capitalization with IPV in Note 2 to the financial statements of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 for additional information relating to the BCA.

The Company’s common stock and warrants are now listed on the New York Stock Exchange stock market under the symbols “AEVA” and "AEVA.WS".

 

Basis of Presentation and Unaudited Interim Financial Statements

The condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). The condensed consolidated financial statements include the accounts of the Company’s wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation.

 

The accompanying condensed consolidated financial statements are unaudited and have been prepared on the same basis as the annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the Company’s financial position, results of operations, comprehensive loss and cash flows for the periods presented, but are not necessarily indicative of the results of operations to be anticipated for any future annual or interim period.

 

These condensed consolidated financial statements and other information presented in this Form 10-Q should be read in conjunction with the consolidated financial statements and the related notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC.

Principal of Consolidation and Liquidity

The condensed consolidated financial statements are prepared in accordance with U.S. GAAP. The condensed consolidated financial statements include the accounts of the Company’s wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

 

The Company has funded its operations primarily through the Business Combination and issuances of stock. As of March 31, 2023, the Company’s existing sources of liquidity included cash and cash equivalents and marketable securities of $288.4 million. The Company has a limited history of operations and has incurred negative cash flows from operating activities and losses from operations in the past as reflected in the accumulated deficit of $345.4 million as of March 31, 2023. The Company expects to continue to incur operating losses due to the investments it intends to make in its business, including product development. Management believes that existing cash and cash equivalents and marketable securities will be sufficient to fund operating and capital expenditure requirements through at least 12 months from the date of issuance of these financial statements.

Significant Risks and Uncertainties

The Company is subject to those risks common in the technology industry and also those risks common to early stage companies including, but not limited to, the possibility of not being able to successfully develop or market its products, technological obsolescence, competition, dependence on key personnel and key external alliances, the successful protection of its proprietary technologies, compliance with government regulations, and the possibility of not being able to obtain additional financing when needed.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, marketable securities, and trade receivables. The Company maintains the majority of its cash and cash equivalents in accounts with large financial institutions. At times, balances in these accounts may exceed federally insured limits; however, to date, the Company has not incurred any

 

---

Table of Contents

 

losses on its deposits of cash and cash equivalents and believes the exposure to risk of loss is not material. Risks associated with the Company’s marketable securities is mitigated by investing in investment-grade rated securities when purchased.

The Company’s accounts receivable are derived from customers located in the United States, Asia, and Europe. The Company mitigates its credit risks by performing ongoing credit evaluations of its customers’ financial conditions and requires customer advance payments in certain circumstances. The Company generally does not require collateral.

As of March 31, 2023, one customer accounted for 59% of the accounts receivable. As of December 31, 2022, one customer accounted for 66% of accounts receivable. As of March 31, 2023, two vendors accounted for 22% of accounts payable. As of December 31, 2022, two vendors accounted for 20% of accounts payable.

Recent Adopted Accounting Pronouncements

In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-08, “Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers” (“ASU 2021-08”), which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured in accordance with ASC 606, Revenue from Contracts with Customers. ASU 2021-08 is effective for interim and annual periods beginning after December 15, 2022 on a prospective basis, with early adoption permitted. The adoption of ASU 2021-08 on January 1, 2023 did not have any impact on the Company’s condensed consolidated financial statements.

 

Note 2. Revenue

Disaggregation of Revenues

The Company disaggregates its revenue from contracts with customers by geographic region based on the primary billing address of the customer and timing of transfer of goods or services to customers (point-in-time or over time), as it believes it best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. Total revenue for the three months ended March 31, 2023 and 2022, based on the disaggregation criteria described above were as follows (in thousands):

 

		Three Months Ended March 31,
		2023								2022
		Revenue				% of Revenue				Revenue				% of Revenue
Revenue by primary geographical market:
North America		$	730				64	%		$	1,111				98	%
EMEA			244				21	%			26				2	%
Asia			174				15	%			—				0	%
Total		$	1,148				100	%		$	1,137				100	%
Revenue by timing of recognition:
Recognized at a point in time		$	947				82	%		$	211				19	%
Recognized over time			201				18	%			926				81	%
Total		$	1,148				100	%		$	1,137				100	%

 

The point in time revenue was primarily related to the product revenue and overtime revenue was from non-recurring engineering services.

For the three months March 31, 2023, three customers accounted for 20%, 19% and 17% of the Company’s revenue, respectively. For the three months ended March 31, 2022, one customer accounted for 81% of the Company’s revenue.

Contract Assets and Contract Liabilities

As of March 31, 2023, and December 31, 2022, the Company had contract assets of $0.4 million and $0.2 million, recognized in other current assets. The Company had no contract liability, as of March 31, 2023 and December 31, 2022.

 

Note 3. Financial Instruments

 

10

---

Table of Contents

 

The following tables summarize the Company’s financial assets and liabilities measured at fair value by level within the fair value hierarchy:

 

		March 31, 2023
		Adjusted Cost				Unrealized Gains				Unrealized Losses				Fair Value				Cash and Cash Equivalent				Marketable Securities
		(in thousands)
Assets
Cash		$	27,933			$	—			$	—			$	27,933			$	27,933			$	—
Level 1
Money market funds			3,931				—				—				3,931				3,931				—
Level 2
U.S. agency securities			70,659				17				(1,081	)			69,595				—				69,595
U.S. Treasury securities			7,476				—				(77	)			7,399				—				7,399
Commercial paper			39,674				1				(46	)			39,629				—				39,629
Corporate bonds			141,106				6				(1,193	)			139,919				—				139,919
Subtotal			258,915				24				(2,397	)			256,542				—				256,542
Total assets		$	290,779			$	24			$	(2,397	)		$	288,406			$	31,864			$	256,542
Liabilities
Level 3
Warrant liabilities			62								—				62				—				—
Total liabilities		$	62			$	—			$	—			$	62			$	—			$	—

 

 

		December 31, 2022
		Adjusted Cost				Unrealized Losses				Fair Value				Cash and Cash Equivalent				Marketable Securities
		(in thousands)
Assets
Cash		$	17,980			$	—			$	17,980			$	17,980			$	—
Level 1
Money market funds			44,443				—				44,443				44,443				—
Level 2
U.S. agency securities			65,493				(1,518	)			63,975				—				63,975
U.S. Treasury securities			14,953				(111	)			14,842				—				14,842
Commercial paper			40,859				(100	)			40,759				4,997				35,762
Corporate bonds			143,669				(1,856	)			141,813				—				141,813
Subtotal			264,974				(3,585	)			261,389				4,997				256,392
Total assets		$	327,397			$	(3,585	)		$	323,812			$	67,420			$	256,392
Liabilities
Level 3
Warrant liabilities			90				—				90				—				—
Total liabilities		$	90			$	—			$	90			$	—			$	—

 

The fair value of the private placement warrant liabilities is based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy. In determining the fair value of the warrant liabilities, the Company used the Black-Scholes option-pricing model to estimate the fair value using unobservable inputs including the expected term, expected volatility, risk-free interest rate, and dividend yield.

 

The following table presents a summary of the changes in the fair value of the Company’s Level 3 financial instruments (in thousand):

 

		March 31, 2023				December 31, 2022
Fair value, beginning balance		$	90			$	1,060
Change in the fair value included in other income, net			(28	)			(970	)
Fair value, closing balance		$	62			$	90

 

11

---

Table of Contents

 

 

The key inputs into the Black-Scholes option pricing model for the private warrants were as follows for the relevant periods:

 

		March 31, 2023				December 31, 2022
Expected term (years)			3.0				3.2
Expected volatility			89.7	%			88.2	%
Risk-free interest rate			3.81	%			4.22	%
Dividend yield			0	%			0	%
Exercise Price		$	11.50			$	11.50

 

Note 4. Acquisition of Intangible Assets

 

As of March 31, 2023, expected amortization expense relating to purchased intangible assets was as follows (in thousands):

 

Remainder of 2023		$	675
2024			900
2025			900
2026			825
Total future amortization		$	3,300

 

The Company recorded amortization expense related to the acquired intangible assets of $0.2 million for each of the three months ended March 31, 2023 and 2022, respectively.

 

Note 5. Inventories

Inventories consisted of the following (in thousands):

 

		March 31,				December 31,
		2023				2022
Raw materials		$	2,750			$	2,743
Work-in-progress			59				42
Finished goods			197				166
Total inventories		$	3,006			$	2,951

 

Note 6. Property, Plant and Equipment

Property, plant and equipment consisted of the following (in thousands):

 

		March 31,				December 31,
		2023				2022
Computer equipment		$	2,363			$	2,363
Lab equipment			5,386				5,055
Leasehold improvements			2,965				2,961
Construction in progress			2,086				1,488
Testing equipment			776				692
Manufacturing equipment			2,513				1,831
Furniture, fixtures and other equipment			535				535
Total property, plant and equipment		$	16,624			$	14,925
Less: accumulated depreciation			(5,935	)			(5,205	)
Total property, plant and equipment, net		$	10,689			$	9,720

 

Depreciation related to property, plant, and equipment was $0.7 million and $0.4 million for the three months ended March 31, 2023 and 2022, respectively.

 

12

---

Table of Contents

 

Note 7. Other current assets

 

Other current assets consisted of the following (in thousands):

 

		March 31,				December 31,
		2023				2022
Prepaid expenses		$	1,918			$	2,343
Contract assets			421				247
Vendor deposits			540				1,398
Other current assets			1,804				1,485
Total other current assets		$	4,683			$	5,473

 

Note 8. Capital Structure

As of March 31, 2023, the Company had authorized to issue up to 422,000,000 shares of common stock, each with a par value of $0.0001 per share.

 

Preferred Stock

The Company is authorized to issue up to 10,000,000 shares of preferred stock, each with a par value of $0.0001 per share. As of March 31, 2023 and December 31, 2022, no shares of preferred stock were issued and outstanding.

Warrants

 

As of March 31, 2023, the Company had 12,074,880 public and 384,000 private warrants outstanding. Each warrant entitles the registered holder to purchase one share of common stock at a price of $11.50 per share.

Note 9. Earnings (Loss) Per Share

The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands, except per share data):

 

		Three Months Ended March 31,
		2023				2022
Numerator:
Net loss attributable to common stockholders		$	(35,174	)		$	(33,157	)
Denominator:
Weighted average shares of common stock outstanding — Basic			219,627,827				216,017,186
Dilutive effect of potential common stock			—				—
Weighted average shares of common stock outstanding — Diluted			219,627,827				216,017,186
Net loss per share attributable to common stockholders — Basic and Diluted		$	(0.16	)		$	(0.15	)

The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been anti-dilutive:

 

		Three Months Ended March 31,
		2023				2022
Common stock options issued and outstanding			13,173,030				12,787,299
Restricted stock units			21,744,565				6,829,309
Warrants			12,458,880				12,458,880
Total			47,376,475				32,075,488

 

Note 10. Stock-based Compensation

Stock Options

The Company maintains the 2016 Stock Incentive Plan and the 2021 Incentive Award Plan (the “Stock Plans”) under which incentive stock options, non-qualified stock options and RSUs may be granted to employees. Under the Stock Plans, the Company has 26,790,558 shares available for issuance as of March 31, 2023.

Under the terms of the Stock Plans, incentive stock options must have an exercise price at or above the fair market value of the stock on the date of the grant, while non-qualified stock options are permitted to be granted below fair market value of the stock on the date of grant. The majority

13

---

Table of Contents

 

of stock options granted have service-based vesting conditions only. The service-based vesting conditions vary though typically, stock options vest over four years with 25% of stock options vesting on the first anniversary of the grant and the remaining 75% vesting monthly over the remaining 36 months. Option holders have a ten-year period to exercise the options before they expire.

A summary of the Company’s stock option activity for three months ended March 31, 2023, was as follows:

 

		Number of Options				Weighted- Average Exercise Price				Weighted- Average Remaining Contractual Life (Years)				Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2022			13,434,083			$	0.67				6.77			$	11,593
Granted			—				—				—				—
Exercised			(236,642	)			0.24				—				—
Forfeited			(24,411	)			0.45				—				—
Outstanding as of March 31, 2023			13,173,030			$	0.68				6.57			$	9,293
Vested and exercisable as of March 31, 2023			10,852,329			$	0.48				6.32			$	8,407
Vested and expected to vest as of March 31, 2023			13,173,030			$	0.68				6.57			$	9,293

There were no options granted during the three months ended March 31, 2023. As of March 31, 2023, the Company had $3.0 million of unrecognized stock-based compensation expense related to the stock options. This cost is expected to be recognized over a weighted-average period of 1.6 years.

Restricted Stock Units and Performance-based Restricted Stock Units

 

Beginning November 2020, the Company granted RSUs and PBRSUs to certain employees and consultants pursuant to the 2016 and 2020 Stock Plan. RSUs typically vest 25 percent upon the one-year anniversary date from the initial vesting date, with 12.5% vesting on each six-month anniversary date over the following three years. The RSUs are subject to a time-based vesting condition and a performance condition tied to the completion of the merger with InterPrivate, both of which must be satisfied in order for the RSUs to be vested and settled for shares of Common Stock. The performance vesting condition for these RSU were met on March 12, 2021.

 

The following table summarizes our RSU activity which includes performance-based RSUs, for the three months ended March 31, 2023:

 

		Shares				Weighted Average Grant Date Fair Value per Share
Outstanding as of December 31, 2022			11,945,375			$	5.22
Granted			12,130,011				1.48
Released			(1,077,527	)			6.09
Forfeited			(1,253,294	)			4.03
Outstanding as of March 31, 2023			21,744,565			$	3.16

 

As of March 31, 2023, the Company had $59.4 million of unrecognized stock-based compensation expense related to the RSUs. This cost is expected to be recognized over a weighted-average period of 3.2 years.

Employee Stock Purchase Plan

In November 2022, the Board and the Company’s stockholders adopted the 2022 Employee Stock Purchase Plan (“ESPP”) under which 12,769,233 shares were authorized for issuance. The ESPP permits eligible employees to purchase the Company’s common stock through payroll deduction with up to 15% of their pre-tax earnings subject to certain Internal Revenue Code limitations. The purchase price of shares is 85% of the lower of the fair market value of the Company’s common stock on the first day of a six-month offering period, or the relevant purchase date. In addition, participants are subject to $25,000 annual purchase restriction. No ESPP shares were purchased during period ended March 31, 2023.

14

---

Table of Contents

 

Compensation expense

Total stock-based compensation expense by function was as follows (in thousands):

 

		Three Months Ended March 31,
		2023				2022
Cost of revenue		$	330			$	136
Research and development expenses			4,410				4,323
General and administrative expenses			1,119				1,229
Sales and marketing expenses			104				96
Total		$	5,963			$	5,784

 

Note 11. Income Taxes

Components of Income (Loss) Before Taxes

For financial reporting purposes, income (loss) before income taxes includes the following components (in thousand):

 

		Three Months Ended March 31,
		2023				2022
Domestic		$	(35,174	)		$	(33,157	)
Foreign			—				—
Loss before income taxes		$	(35,174	)		$	(33,157	)

 

There has historically been no federal or state provision for income taxes because the Company has historically incurred operating losses and maintains a full valuation allowance against its net deferred tax assets. For the three months ended March 31, 2023 and 2022, the Company recognized no provision for income taxes.

The federal and state net operating loss carryforwards may be subject to significant limitations under Section 382 and Section 383 of the Internal Revenue Code of 1986, as amended, and similar provisions under state law. The Tax Reform Act of 1986 contains provisions that limit the federal net operating loss carryforwards that may be used in any given year in the event of special occurrences, including significant ownership changes. The Company has completed an analysis as of December 31, 2022 and doesn’t expect any net operating loss carryforwards or tax credit carryforwards to expire due to a limitation.

Note 12. Commitments and Contingencies

Leases

The weighted-average remaining lease terms were 2.6 years and 2.8 years as of March 31, 2023 and December 31, 2022, respectively. The weighted-average discount rates were 5.25% as of March 31, 2023 and December 31, 2022, respectively. Operating lease cost for three months ended March 31, 2023 and 2022, were $0.8 million and $0.8 million, respectively.

The following is a maturity analysis of the annual undiscounted cash flows reconciled to the carrying value of the operating lease liabilities as of March 31, 2023 (in thousands):

 

		Operating Leases
Remainder of 2023		$	2,133
2024			2,748
2025			1,969
2026			290
Total minimum lease payments			7,140
Less: imputed interest			(438	)
Total lease liability		$	6,702

 

Litigation

From time to time, the Company is involved in actions, claims, suits, and other proceedings in the ordinary course of business, including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties, or employment-related matters. When it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated, the Company records a liability for such loss contingencies. The Company’s estimates regarding potential losses and materiality are based on the Company’s judgment and assessment of the claims utilizing currently available information. Although the Company will continue to reassess its reserves and estimates based on future developments, the Company’s objective assessment of the legal merits of such claims may not always be predictive of the outcome and actual results may vary from the Company’s current estimates.

15

---

Table of Contents

 

Indemnifications

In the ordinary course of business, the Company is not subject to potential obligations under guarantees that fall within the scope of FASB ASC Guarantees, (Topic 460), except for standard indemnification provisions that are contained within many of the Company’s customer agreements and give rise only to disclosure requirements prescribed by Topic 460. Indemnification provisions contained within the Company’s customer agreements are generally consistent with those prevalent in the Company’s industry. The Company has not incurred any obligations under customer indemnification provisions and does not expect to incur significant obligations in the future. Accordingly, the Company does not maintain accruals for potential customer indemnification obligations.

Note 13. Segment Information

The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision-maker (“CODM”), consisting of the Company’s chief executive officer and the Company’s chief technology officer as a group, in deciding how to allocate resources and assess the Company’s financial and operational performance. In addition, the Company’s CODM evaluates the Company’s financial information and resources and assesses the performance of these resources on a consolidated basis. As a result, the Company has determined that the Company’s business operates in a single operating segment. Since the Company operates as one operating segment, all required financial segment information can be found in the financial statements.

Long-Lived Assets

The following table sets forth the Company’s property and equipment, net by geographic region (in thousand):

		March 31,				December 31,
		2023				2022
North America		$	9,038			$	8,236
Asia			1,597				1,379
EMEA			54				105
Total		$	10,689			$	9,720

 

16

---

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following discussion of Aeva’s results of operations and financial condition should be read in conjunction with the information set forth in the financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q. This discussion may contain forward-looking statements based upon Aeva’s current expectations, estimates, and projections that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements due to, among other considerations, the matters discussed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”) under the heading “Risk Factors” and “Special Note Regarding Forward-Looking Statements.” Unless the context otherwise requires, all references in this section to “we,” “our,” “us” “the Company” or “Aeva” refer to the business of Aeva Technologies, Inc., a Delaware corporation, and its subsidiaries.

Overview

 

Our vision is to bring perception to broad applications. Through our FMCW sensing technology, we believe we are introducing the world’s first 4D LiDAR-on-chip that, along with our proprietary software applications, has the potential to enable the adoption of LIDAR across broad applications.

Founded in 2017 by former Apple engineers Soroush Salehian and Mina Rezk and led by a multidisciplinary team of engineers and operators experienced in the field of sensing and perception, Aeva’s mission is to bring the next wave of perception technology to broad applications from automated driving to industrial automation, consumer device applications, and security. Our 4D LiDAR-on-chip combines silicon photonics technology that is proven in the telecom industry with precise instant velocity measurements and long-range performance for commercialization.

As a development stage company, we work closely with our customers on the development and commercialization of their programs and the utilization of our products in such programs. Thus far, our customers have purchased prototype products and engineering services from us for use in their research and development programs. We are expanding our manufacturing capacity through third-party manufacturers to meet our customers’ anticipated demand for the production of our products.

Unlike legacy 3D LiDAR, which relies on Time-of-Flight (“ToF”) technology and measures only depth and reflectivity, Aeva’s solution leverages a proprietary FMCW technology to measure velocity in addition to depth, reflectivity and inertial motion. We believe the ability of Aeva’s solution to measure instant velocity for every pixel is a major advantage over ToF-based sensing solutions. Furthermore, Aeva’s technology is free from interference from other LiDAR and sunlight, and our core innovations within FMCW are intended to enable autonomous vehicles to see at significantly higher distances of up to 500 meters.

We believe Aeva is uniquely positioned to provide a superior solution with the potential to enable higher level of automation for vehicles. Furthermore, we believe the advantages of our 4D LiDAR-on-chip allow us to provide the first LiDAR solution that is fully integrated onto a chip with superior performance at scale, with the potential to drive new categories of perception across industrial automation, consumer devices, and security markets.

Key Factors Affecting Aeva’s Operating Results

Aeva believes that its future performance and success depends to a substantial extent on its ability to capitalize on the following opportunities, which in turn is subject to significant risks and challenges, including those discussed in Part I, Item 1A of the 2022 Form 10-K under the heading “Risk Factors.”

Pricing, Product Cost and Margins. Our pricing and margins will depend on the volumes and the features, as well as specific market applications of the solutions we provide to our customers. We have customers with technologies in various stages of development across different market segments. We anticipate that our prices will vary by market and application due to market-specific product and commercial requirements, supply and demand dynamics and product lifecycles.

Aeva's future performance will depend on its ability to deliver on economies of scale with lower product costs to enable industry adoption. Aeva believes its business model is positioned for scalability due to the ability to leverage the same product platform across markets and customer base, relationships with leading foundries and contract manufacturers. Our customers will require that our perception solutions be manufactured and sold at per-unit prices that are competitive. Our ability to compete in key markets will depend on the success of our efforts to efficiently and reliably produce cost-effective perception solutions that are competitively priced and affordable for our commercial-stage customers.

Additionally, the macroeconomic conditions in the industry, the growing emergence of competition in advanced assisted driving sensing and software technologies globally can negatively impact pricing, margins and market share. If Aeva does not generate the margins it expects upon commercialization of its perception solutions, Aeva may be required to raise additional debt or equity capital, which may not be available or may only be available on terms that are onerous to Aeva’s stockholders.

Commercialization of LiDAR-based Applications. We expect that our results of operations, including revenue and gross margins, will fluctuate on a quarterly basis for the foreseeable future as our customers continue on research and development projects and begin to commercialize advanced driver assist, autonomous and industrial automation solutions that rely on LiDAR technology. As more customers reach the commercialization phase and as the market for LiDAR solutions matures, these fluctuations in our operating results may become less pronounced.

17

---

Table of Contents

Sales Volume. Each product program will have an expected range of sales volumes, depending on the end market demand for our customers’ products as well as market application. This can depend on several factors, including market penetration, product capabilities, size of the end market that the product addresses and our end customers’ ability to sell their products. In addition to end market demand, sales volumes also depend on whether our customer is in the development or production phase. In certain cases, we may provide volume discounts or strategic customer pricing on sales of our solutions, which may or may not be offset by lower manufacturing costs related to higher volumes which in turn could adversely impact our gross margins. Aeva’s ability to ultimately achieve profitability is dependent upon progression of existing relationships to production and our ability to meet required volumes and required cost targets and gross margins. Delays of our current and future customers’ programs could result in Aeva being unable to achieve its revenue targets and profitability in the time frame it anticipates. Such delays could result in Aeva requiring to raise additional debt or equity capital, which may not be available or may only be available on terms that are onerous to Aeva’s stockholders.

Basis of Presentation

Aeva currently conducts its business through one operating segment.

Components of Results of Operations

Revenue

Revenue consists of sales of perception solutions or sensing systems and non-recurring engineering services.

Aeva is engaged in design, manufacturing and sale of LiDAR sensing systems and related perception and autonomy-enabling software solutions serving customers in automotive, industrial, and other markets. Under the customer agreements, Aeva delivers a specified number of sensing systems at a fixed price under customary terms and conditions. The sensing system units sold under these agreements are typically prototypes that are used by the customer for its research, development, evaluation, pilot, or testing purposes. Aeva also enters into non-recurring engineering service arrangements with certain of its customers to customize Aeva’s perception solution to meet customer specific requirements.

Cost of revenue and gross profit

Cost of revenue principally includes direct material, direct labor and allocation of overhead associated with manufacturing operations, including inbound freight charges and depreciation expense. Cost of revenue also includes the direct cost and appropriate allocation of overhead involved in execution of non-recurring engineering services. Aeva’s gross profit equals total revenue less total cost of revenue.

Operating expenses

Research and development expenses

Aeva’s research and development efforts are focused on enhancing and developing additional functionality for its existing products and on new product development. Research and development expenses consist primarily of:

•

Personnel-related expenses, including salaries, benefits, and stock-based compensation expense, for personnel in Aeva’s research and engineering functions; and

•

Expenses related to materials, software licenses, supplies, and third-party services.

Aeva recognizes research and development expenses as incurred. Aeva expects its research and development expenses to remain at same level as fiscal 2022 or increase slightly in the foreseeable future as it continues to invest in research and development activities to achieve its product roadmap.

General and administrative expenses

General and administrative expenses consist of personnel and personnel-related expenses, including salaries, benefits, and stock-based compensation expense of Aeva’s executive, finance, information systems, human resources, and legal, as well as legal and accounting fees for professional and contract services. Aeva expects its general and administrative expenses to remain at same level as fiscal 2022 or increase slightly in the foreseeable future as it scales headcount with the growth of its business, and as a result of operating as a public company, including compliance with the rules and regulations of the Securities and Exchange Commission (the “SEC”), legal, audit, additional insurance expenses, investor relations activities, and other administrative and professional services.

Selling and marketing expenses

Selling and marketing expenses consist of personnel and personnel-related expenses, including salaries, benefits, and stock-based compensation expense of Aeva’s business development team as well as advertising and marketing expenses. These include the cost of trade shows, promotional materials, and public relations. Aeva expects to increase its sales and marketing activities and expand customer relationships. Aeva expects that its sales and marketing expenses will remain at same level as fiscal 2022 or increase slightly over time as it continues to grow its sales force and increase marketing efforts.

18

---

Table of Contents

Interest income and Interest expense

Interest income consists primarily of income earned on Aeva’s cash equivalents and investments in marketable securities. Interest income will vary based on Aeva’s cash equivalents and marketable securities balance and changes in the interest rates.

Other income and expense

Other income and expense primarily consist of changes in the fair value of private placement warrants, foreign currency conversion gains and losses, and realized gains and losses on marketable securities.

Results of Operations

Comparison of the Three Months Ended March 31, 2023, and 2022

The results of operations presented below should be reviewed in conjunction with the financial statements and notes included elsewhere in this quarterly statement. The following table sets forth Aeva’s results of operations data for the periods presented:

 

		Three Months Ended March 31,
		2023				2022				Change $				Change %
		(in thousands, except percentages)
Revenue		$	1,148			$	1,137				11				1	%
Cost of revenue			2,529				1,375				1,154				84	%
Gross loss			(1,381	)			(238	)			(1,143	)			480	%
Operating expenses:
Research and development expenses			25,454				25,315				139				1	%
General and administrative expenses			7,833				6,872				961				14	%
Selling and marketing expenses			2,598				1,648				950				58	%
Total operating expenses			35,885				33,835				2,050				6	%
Loss from operations			(37,266	)			(34,073	)			(3,193	)			9	%
Interest income			2,064				283				1,781				629	%
Other income, net			28				633				(605	)			(96	)%
Net loss before taxes			(35,174	)			(33,157	)			(2,017	)			6	%
Income tax provision			—				—				-
Net loss		$	(35,174	)		$	(33,157	)			(2,017	)			6	%

Revenue

Revenue increased marginally during the three months year ended March 31, 2023 as compared to the three months ended March 31, 2022. The increase was due to increase in revenue from the sale of prototype units sold during the three months ended March 31, 2023 as compared to the three months ended March 31, 2022. This was partially offset by a decrease in the activity related to non-recurring engineering services, which is dependent upon the timing of the work performed for our customers.

Cost of revenue

Cost of revenue increased by $1.2 million or 84%, during the three months ended March 31, 2023, from the three months ended March 31, 2022. The increase was primarily due to an increase in manufacturing overhead costs due to scaling of third-party contract manufacturing, and an increase in number of units sold during period ended March 31, 2023. This was partially offset by the impairment of inventory of $0.7 million recorded during the three months ended March 31, 2022.

Operating expenses

Research and development expenses

Total research and development expenses increased marginally by $0.1 million, or 1%, to $25.4 million for the three months ended March 31, 2023, from $25.3 million for the three months ended March 31, 2022. Research and development expenses increased primarily due to an increase of $1.1 million in payroll expenses, primarily resulting from continued expansion for product development. This was partially offset by a decrease in consulting and professional services of $1.0 million.

General and administrative expenses

Total general and administrative expense increased by $1.0 million, or 14%, to $7.8 million for the three months ended March 31, 2023, from $6.9 million for the three months ended March 31, 2022. General and administrative expense increased primarily due to an increase in the employee related costs. Payroll related expenses increased by $0.5 million, other employee related expense increased by $0.5 million and depreciation expense increased by $0.3 million, this was partially offset by a decrease in the professional service costs by $0.3 million.

19

---

Table of Contents

Selling and marketing expenses

Total selling and marketing expense increased by $1.0 million, or 58%, to $2.6 million for the three months ended March 31, 2023, from $1.6 million for the three months ended March 31, 2022. The increase in sales and marketing expense was primarily due to an increase in marketing related expense of $0.4 million, an increase in payroll expenses of $0.5 million driven by additional headcount and an increase in professional services of $0.1 million.

Interest income

Interest income increased by $1.8 million during the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The increase was due to an increase in the interest rate during the three months ended March 31, 2023 as compared to the three months ended March 31, 2022.

Other income, net

 

Other income decreased by $0.6 million for the three months ended March 31, 2023 primarily due to change in in the fair value of private placement warrant liability which was recorded as other income.

Liquidity and Capital Resources

Sources of Liquidity

Aeva’s capital requirements will depend on many factors, including sales volume, the timing and extent of spending to support research and development efforts, investments in information technology systems, the expansion of sales and marketing activities, and market adoption of new and enhanced products and features. As of March 31, 2023, Aeva had cash and cash equivalents and marketable securities totaling $288.4 million.

Aeva expects its current cash and cash equivalents and marketable securities, to fund its near term cash needs but will be required to raise additional capital unless Aeva is able to generate sufficient revenue from the sale of its products to cover anticipated operating expense, working capital and capital expenditures. Any additional equity securities issued may provide for rights, preferences or privileges senior to those of holders of the Company’s common stock. If Aeva raises funds by issuing debt securities, these debt securities would have rights, preferences and privileges senior to those of common stockholders. The terms of debt securities or borrowings could impose significant restrictions on Aeva’s operations. Further, the current macroeconomic environment may make it difficult for us to raise capital on terms favorable to us or at all. The credit market and financial services industry have in the past, and may in the future, experience periods of uncertainty and other risks detailed in Part I, Item 1A titled “Risk Factors” that could impact the availability and cost of equity and debt financing.

Aeva has incurred negative cash flows from operating activities and losses from operations in the past as reflected in its accumulated deficit of $345.4 million as of March 31, 2023. Aeva expects to continue to incur operating losses due to continued investments that it intends to make in its business, including development of products. Aeva believes that existing cash and cash equivalent and marketable securities will be sufficient to fund operating and capital expenditure requirements through at least 12 months from the date of issuance of these financial statements.

Cash Flow Summary

The following table summarizes our cash flows for the periods presented:

 

		Three Months Ended March 31,
		2023				2022
		(in thousands)
Cash used in operating activities		$	(36,012	)		$	(26,538	)
Cash provided by investing activities			419				22,040
Cash provided by financing activities			37				187
Net decrease in cash and cash equivalents		$	(35,556	)		$	(4,311	)

 

Operating Activities

For the three months ended March 31, 2023, net cash used in operating activities was $36.0 million, attributable to a net loss of $35.2 million and a net change in net operating assets and liabilities of $7.9 million, partially offset by non-cash charges of $7.0 million. Non-cash charges primarily consisted of $6.0 million in stock-based compensation, $1.0 million in depreciation and amortization expense, $0.7 million in amortization of right of use assets, partially offset by $0.6 million in amortization of premium and accretion of discount on available for sale securities. The change in net operating assets and liabilities was primarily due to a $0.4 million decrease in accounts receivable, a $0.8 million decrease in other current assets due to timing of billing and cash collections, a $1.7 million decrease in accounts payable, a $5.2 million decrease in accrued liabilities, a $1.3 million decrease in accrued employee cost due to bonus payment and a $0.7 million decrease in lease liability, partially offset by a $0.1 million increase in inventory.

20

---

Table of Contents

Investing Activities

For the three months ended March 31, 2023, net cash provided by used in investing activities was $0.4 million, attributable to maturity of available-for-sale investments of $56.2 million, partially offset by purchase of investments of $54.5 million and purchase of property, plant and equipment of $1.3 million.

Financing Activities

For the three months ended March 31, 2023, net cash provided by financing activities was attributable to proceeds from stock option exercises.

 

Off-Balance Sheet Arrangements

As of March 31, 2023, Aeva has not engaged in any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.

Critical Accounting Policies and Estimates

Aeva prepares its financial statements in accordance with U.S. GAAP. The preparation of these financial statements requires the Company to make estimates, assumptions and judgments that can significantly impact the amounts Aeva reports as assets, liabilities, revenue, costs and expenses and the related disclosures. Aeva bases its estimates on historical experience and other assumptions that it believes are reasonable under the circumstances. Aeva’s actual results could differ significantly from these estimates under different assumptions and conditions. Aeva believes that the accounting policies discussed below are critical to understanding its historical and future performance as these policies involve a greater degree of judgment and complexity.

For the three months ended March 31, 2023 there were no significant changes to our critical accounting policies and estimates. For a more detailed discussion of our critical accounting policies and estimates, please refer to our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and Note 1 of the notes to condensed consolidated financial statements included in this Form 10-Q.

Recent Accounting Pronouncements

See Note 1 to Aeva’s financial statements included elsewhere in this Quarterly Report on Form 10-Q for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted as of the date of this Quarterly Report on Form 10-Q.

21

---

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Aeva is exposed to market risk in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in interest rates. There has been no material change in our exposure to market risks from that discussed in Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” of the 2022 Form 10-K.

 

Item 4. Controls and Procedures.

Evaluation of disclosure controls and procedures

 

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2023. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Based on the evaluation of our disclosure controls and procedures as of March 31, 2023, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

 

Changes in internal control over financial reporting

 

There was no change in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Inherent limitation on the effectiveness of internal control

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

22

---

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, the Company may be involved in actions, claims, suits and other proceedings in the ordinary course of business, including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties or employment-related matters. When it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated, the Company records a liability for such loss contingencies. The Company’s estimates regarding potential losses and materiality are based on the Company’s judgment and assessment of the claims utilizing currently available information. Although the Company will continue to reassess its reserves and estimates based on future developments, the Company’s objective assessment of the legal merits of any such claims may not always be predictive of the outcome and actual results may vary from the Company’s current estimates.

 

Item 1A. Risk Factors.

The Company’s business, reputation, results of operations and financial condition, as well as the price of the Company’s stock, can be affected by a number of factors, whether currently known or unknown, including those described in Part I, Item 1A of the 2022 Form 10-K under the heading “Risk Factors.” When any one or more of these risks materialize from time to time, the Company’s business, reputation, results of operations and financial condition, as well as the price of the Company’s stock, can be materially and adversely affected. There have been no material changes to the Company’s risk factors since the 2022 Form 10-K.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceed

 

None.

 

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

23

---

Table of Contents

Item 6. Exhibits.

 

Exhibit Number		Description
3.1		Second Amended and Restated Certificate of Incorporation of Aeva Technologies, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by the Registrant on March 18, 2021).
3.2		Amended and Restated By-laws of Aeva Technologies, Inc. (incorporated by reference to Exhibit 3.2 to the Current Report on Form 8-K filed by the Registrant on March 18, 2021).
31.1*		Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

* Filed herewith.

# Indicates a management contract or any compensatory plan, contract or arrangement.

† Schedules and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.

24

---

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

		AEVA TECHNOLOGIES, INC.
Date: May 11, 2023		By:	/s/Soroush Salehian Dardashti
			Soroush Salehian Dardashti
			Chief Executive Officer
Date: May 11, 2023		By:	/s/ Saurabh Sinha
			Saurabh Sinha
			Chief Financial Officer

 

25

---